Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardiology and Angiology 2025 April;73(2) > Minerva Cardiology and Angiology 2025 April;73(2):184-91

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Cardiology and Angiology 2025 April;73(2):184-91

DOI: 10.23736/S2724-5683.24.06596-7

Copyright © 2024 EDIZIONI MINERVA MEDICA

language: English

Upregulation of serum miR-4429 discriminates chronic heart failure patients and regulates cardiomyocyte injury via modulating HAPLN1

He SUN 1, Yiming YU 2, Xiao GE 2, Lifang CAO 2, Feng LI 2, Jingjing WU 3 ✉

 

ACCESS OPTIONS

Purchase access

You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of  € 45,00.

Downloading and printing for personal use allowed.

Regain access


Personal subscriptions

Access as an individual subscriber


Institutional access

Access through your institution

Subscribe to this journal

Subscribe to Minerva Cardiology and Angiology


Recommend to your librarian

top of page

 

Copyright © 2025 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions